Cargando…

FOS-Like Antigen 1 Expression Was Associated With Survival of Hepatocellular Carcinoma Patients

BACKGROUND: Early diagnosis and proper management of hepatocellular carcinoma (HCC) improve patient prognosis. Several studies attempted to discover new genes to understand the pathogenesis and identify the prognostic and predictive factors in HCC patients, to improve patient’s overall survival (OS)...

Descripción completa

Detalles Bibliográficos
Autores principales: Taha, Noura Ali, Shafiq, Ahmed Mahran, Mohammed, Abdallah Hedia, Zaky, Amen Hamdy, Omran, Ola M., Ameen, Mahmoud Gamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409557/
https://www.ncbi.nlm.nih.gov/pubmed/37560339
http://dx.doi.org/10.14740/wjon1608
_version_ 1785086272492011520
author Taha, Noura Ali
Shafiq, Ahmed Mahran
Mohammed, Abdallah Hedia
Zaky, Amen Hamdy
Omran, Ola M.
Ameen, Mahmoud Gamal
author_facet Taha, Noura Ali
Shafiq, Ahmed Mahran
Mohammed, Abdallah Hedia
Zaky, Amen Hamdy
Omran, Ola M.
Ameen, Mahmoud Gamal
author_sort Taha, Noura Ali
collection PubMed
description BACKGROUND: Early diagnosis and proper management of hepatocellular carcinoma (HCC) improve patient prognosis. Several studies attempted to discover new genes to understand the pathogenesis and identify the prognostic and predictive factors in HCC patients, to improve patient’s overall survival (OS) and maintain their physical and social activity. The transcription factor FOS-like antigen 1 (FOSL1) acts as one of the important prognostic factors in different tumors, and its overexpression correlates with tumors’ progression and worse patient survival. However, its expression and molecular mechanisms underlying its dysregulation in human HCC remain poorly understood. Our study was conducted to evaluate the expression of FOSL1 in HCC tissues and its relationship with various clinicopathological parameters besides OS. METHODS: This study is a retrospective cohort study conducted among 113 patients with a proven diagnosis of HCC, who underwent tumor resection and received treatment at South Egypt Cancer Institute. Immunohistochemistry for FOSL1 expression and survival curves were conducted followed by statistical analysis. RESULTS: HCC occurred at older age group and affected males more than females. There was a statistically significant correlation between combined cytoplasmic and nuclear expression of FOSL1 and worse prognosis in HCC patients. There was a statistically significant correlation of FOSL1 expression with histological grade, lymphovascular embolization, and tumor budding where high expression indicated potential deterioration of HCC patients. There was statistically significant correlation between tumor size, tumor grade and FOSL1 expression with the cumulative OS. CONCLUSIONS: Combined cytoplasmic and nuclear FOSL1 expression has significant prognostic association with HCC and diagnostic importance, as it can identify cirrhosis and premalignant lesions that can progress to HCC. Furthermore, Kaplan-Meier survival analysis found that overexpressed FOSL1 was correlated with poor OS.
format Online
Article
Text
id pubmed-10409557
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-104095572023-08-09 FOS-Like Antigen 1 Expression Was Associated With Survival of Hepatocellular Carcinoma Patients Taha, Noura Ali Shafiq, Ahmed Mahran Mohammed, Abdallah Hedia Zaky, Amen Hamdy Omran, Ola M. Ameen, Mahmoud Gamal World J Oncol Original Article BACKGROUND: Early diagnosis and proper management of hepatocellular carcinoma (HCC) improve patient prognosis. Several studies attempted to discover new genes to understand the pathogenesis and identify the prognostic and predictive factors in HCC patients, to improve patient’s overall survival (OS) and maintain their physical and social activity. The transcription factor FOS-like antigen 1 (FOSL1) acts as one of the important prognostic factors in different tumors, and its overexpression correlates with tumors’ progression and worse patient survival. However, its expression and molecular mechanisms underlying its dysregulation in human HCC remain poorly understood. Our study was conducted to evaluate the expression of FOSL1 in HCC tissues and its relationship with various clinicopathological parameters besides OS. METHODS: This study is a retrospective cohort study conducted among 113 patients with a proven diagnosis of HCC, who underwent tumor resection and received treatment at South Egypt Cancer Institute. Immunohistochemistry for FOSL1 expression and survival curves were conducted followed by statistical analysis. RESULTS: HCC occurred at older age group and affected males more than females. There was a statistically significant correlation between combined cytoplasmic and nuclear expression of FOSL1 and worse prognosis in HCC patients. There was a statistically significant correlation of FOSL1 expression with histological grade, lymphovascular embolization, and tumor budding where high expression indicated potential deterioration of HCC patients. There was statistically significant correlation between tumor size, tumor grade and FOSL1 expression with the cumulative OS. CONCLUSIONS: Combined cytoplasmic and nuclear FOSL1 expression has significant prognostic association with HCC and diagnostic importance, as it can identify cirrhosis and premalignant lesions that can progress to HCC. Furthermore, Kaplan-Meier survival analysis found that overexpressed FOSL1 was correlated with poor OS. Elmer Press 2023-08 2023-07-12 /pmc/articles/PMC10409557/ /pubmed/37560339 http://dx.doi.org/10.14740/wjon1608 Text en Copyright 2023, Taha et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Taha, Noura Ali
Shafiq, Ahmed Mahran
Mohammed, Abdallah Hedia
Zaky, Amen Hamdy
Omran, Ola M.
Ameen, Mahmoud Gamal
FOS-Like Antigen 1 Expression Was Associated With Survival of Hepatocellular Carcinoma Patients
title FOS-Like Antigen 1 Expression Was Associated With Survival of Hepatocellular Carcinoma Patients
title_full FOS-Like Antigen 1 Expression Was Associated With Survival of Hepatocellular Carcinoma Patients
title_fullStr FOS-Like Antigen 1 Expression Was Associated With Survival of Hepatocellular Carcinoma Patients
title_full_unstemmed FOS-Like Antigen 1 Expression Was Associated With Survival of Hepatocellular Carcinoma Patients
title_short FOS-Like Antigen 1 Expression Was Associated With Survival of Hepatocellular Carcinoma Patients
title_sort fos-like antigen 1 expression was associated with survival of hepatocellular carcinoma patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409557/
https://www.ncbi.nlm.nih.gov/pubmed/37560339
http://dx.doi.org/10.14740/wjon1608
work_keys_str_mv AT tahanouraali foslikeantigen1expressionwasassociatedwithsurvivalofhepatocellularcarcinomapatients
AT shafiqahmedmahran foslikeantigen1expressionwasassociatedwithsurvivalofhepatocellularcarcinomapatients
AT mohammedabdallahhedia foslikeantigen1expressionwasassociatedwithsurvivalofhepatocellularcarcinomapatients
AT zakyamenhamdy foslikeantigen1expressionwasassociatedwithsurvivalofhepatocellularcarcinomapatients
AT omranolam foslikeantigen1expressionwasassociatedwithsurvivalofhepatocellularcarcinomapatients
AT ameenmahmoudgamal foslikeantigen1expressionwasassociatedwithsurvivalofhepatocellularcarcinomapatients